Stemson Chief Scientific Officer, Kevin D’Amour, Interviews with Cell & Gene Therapy Insights
February 16, 2024
Kevin D’Amour, Stemson’s Chief Scientific Officer, speaks with Cell & Gene Therapy Insights about developing an iPSC-derived cell therapy solution to engineer follicular units to treat hair loss.